NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England

CPV: Health services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

16 Mar 2026, 15:26 GMT

Last source update

31 Mar 2026, 09:27 BST

Authority reference

NHSE1051

FTS notice number

2026/S 000-029417

Classification (CPV)

Health services

Delivery area

North West (UKD)

Official registry OCID

ocds-h6vhtk-066b53 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

The Relevant Authority intends to issue a contract via Direct Award Process C.

The Relevant Authority has taken into account the key criteria and applied the basic selection criteria, and is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by 27 March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: [email protected] The award decision was made on 16 March 2026 by the North West Specialised Commissioning Senior Leaders Team. The Relevant Authority, as part of the Direct Award C process, have reviewed the key criteria. The evidence shows that the Provider can satisfy the proposed new contract. The information gathered evidences that the incumbent provider meets the key criteria and gives assurance that they can continue to provide the service within the new contract. The current Provider is providing a quality service which meets the needs of the population they serve and is continually addressing and reducing inequalities in both service, access and outcomes. It shows the current provider is treating both patients and staff with equality and are continually seeking improvements in social value including their environment. All involved in the process completed a conflict of interest declaration. No conflicts were identified.

• Manchester University Foundation TrustAwarded supplierGB-CHC: 1049274 Cobbett House, Oxford Road, Manchester, North West, M13 9WL

No document links were published on the notice.